Patients in East Yorkshire and North Lincolnshire are set to benefit from quicker treatment.
Trending
- Activating RARβ to overcome immunomodulatory drug resistance in t(4;14) human myeloma
- Merseyside lung cancer patient first in world to get new vaccine
- SMARCA2 and SMARCA4-deficiency is associated with a distinct molecular and microenvironmental subtype of esophageal adenocarcinoma
- Relapsed childhood cancers show genomic scars left by previous therapy
- Introduction to BCMA-Directed Therapies in Relapsed/Refractory Multiple Myeloma
- Advancing Multidisciplinary Care and Health Equity in Metastatic Breast Cancer
- Linvoseltamab Data and Clinical Perspectives in Relapsed/Refractory Multiple Myeloma
- SETD8-mediated mono-methylation of YAP at K76 promotes K48-linked polyubiquitination and degradation to suppress colorectal cancer

